We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

142 hedge funds and large institutions have $1.17B invested in Amedisys in 2015 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

54% more capital invested

Capital invested by funds: $758M → $1.17B (+$408M)

22% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $13.2M

7% more funds holding

Funds holding: 133142 (+9)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 55

Holders
142
Holders Change
+9
Holders Change %
+6.77%
% of All Funds
3.83%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
48
Reduced
55
Closed
11
Calls
$16.1M
Puts
$13.2M
Net Calls
+$2.91M
Net Calls Change
-$1.04M
Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$192M
NTC
2
North Tide Capital
Massachusetts
$159M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$143M
Vanguard Group
4
Vanguard Group
Pennsylvania
$83.6M -$374K -11,996 -0.6%
BFA
5
BlackRock Fund Advisors
California
$77.9M -$1.12M -35,884 -2%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$76.2M -$2.39M -76,580 -4%
BIT
7
BlackRock Institutional Trust
California
$32.8M -$1.65M -52,946 -6%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$28.5M -$3.2M -102,593 -12%
Northern Trust
9
Northern Trust
Illinois
$25.5M -$259K -8,319 -1%
State Street
10
State Street
Massachusetts
$24M +$9.81K +315 +0.1%
Millennium Management
11
Millennium Management
New York
$21.7M -$7.16M -229,762 -30%
GAM
12
Gotham Asset Management
New York
$15.7M +$11.1M +355,859 +900%
DCM
13
Decade Capital Management
New York
$15.2M -$32.4K -1,041 -0.3%
BA
14
BlackRock Advisors
Delaware
$15M +$11.2M +357,938 +1,912%
Deutsche Bank
15
Deutsche Bank
Germany
$13.2M +$4.89M +156,885 +89%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$12.5M +$526K +16,885 +6%
Morgan Stanley
17
Morgan Stanley
New York
$9.56M +$393K +12,624 +6%
BG
18
BlackRock Group
United Kingdom
$9.26M +$6.44M +206,692 +787%
Norges Bank
19
Norges Bank
Norway
$9.15M -$2.22M -71,132 -24%
Invesco
20
Invesco
Georgia
$8.44M +$1.21M +38,905 +22%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$8.38M +$239K +7,664 +4%
Principal Financial Group
22
Principal Financial Group
Iowa
$8.36M +$57K +1,830 +0.9%
PPA
23
Parametric Portfolio Associates
Washington
$8.32M -$610K -19,575 -9%
Adage Capital Partners
24
Adage Capital Partners
Massachusetts
$7.95M +$6.23M +200,000 New
HAI
25
Hennessy Advisors Inc
California
$7.17M -$414K -13,300 -7%

AMED Hedge Fund Activity: Q2 2015 in Review

142 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2015, worth a combined $1.17B — up 54% from $758M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AMED positions and 11 closed out — a net gain of 11 holders — while 48 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $11.2M. The largest seller was Millennium Management, cutting an estimated $7.16M.

  • 142 institutional investors held Amedisys (AMED) as of Q2 2015, up from 133 in Q1 2015.
  • Funds reported $1.17B of Amedisys stock for Q2 2015, up 54% quarter-over-quarter.
  • 22 funds opened new Amedisys positions in Q2 2015 and 11 closed out, a net change of +11 holders.
  • The largest Amedisys buyer in Q2 2015 was BlackRock Advisors, an estimated $11.2M added.
  • The largest Amedisys seller in Q2 2015 was Millennium Management, an estimated $7.16M sold.

Based on aggregated 13F filings for Q2 2015.